01 June 2002
Hepatopulmomary syndrome – known symptoms and new name
Andrzej Dziedziczko, Zbigniew BartuziCase Rep Clin Pract Rev 2002; 3(2):121-127 :: ID: 474860
Abstract
The term ‘hepatopulmonary syndrome’ refers to a clinical correlation between impaired hepatic function and pulmonary blood vessel distension accompanied by abnormalities in arterial blood oxygenation. Hepatopulmonary
syndrome develops in patients with advanced liver diseases, most frequently cirrhosis or chronic active hepatitis. Patients with fully developed hepatopulmonary syndrome present respiratory symptoms such as cyanosis,
dyspnea, platypnea, orthodeoxia, clubbed fingers. Platypnea is dyspnea occurring due to assuming a sitting position, which subsides after lying down, while orthodeoxia is a decrease of oxygen pressure in capillary blood
associated with assuming a sitting position. Hepatopulmonary syndrome and consequent respiratory symptoms are due to vascular changes involving distension of precapillaries, presence of arteriovenous shunts within the lungs and so-called spider angiomas in the pleura. Precapillary and capillary distension leads to impairment of perfusion and diffusion mechanisms,
Consequently, the mixture of arterial and venous blood passes to the pulmonary veins, which leads to hypoxia. According to the predominating opinion, angiotensin II is an etiologic factor for this syndrome. The development
of hepatopulmonary syndrome symptoms, due to vascular distension, is believed to be associated with abnormal response to angiotensin II (reducet vasoconstricting effect) and with simultaneous inscrease of the concentration
of nitrogen oxide – a vasodilating factor. The diagnostic criteria include: 1) documented acute or chronic liver disease, 2) presence of pulmonary vascular distension and increased alveoloarterial gradient in the respiratory process. It has been emphasized that liver transplantation, is the only effective method of treatment, providing at the same time evidence for the reversibility of hepatopulmonary syndrome. The attempts of pharmacological treatment undertaken so far have yielded disappointing results. Further search for new methods of treatment effective in hepatopulmonary syndrome is necesary.
Keywords: hepatopulmonary syndrome, orthodeoxia, platypnea, pathogenesis, diagnostics, treatment
37
In Press
05 Mar 2024 : Case report
Transformation of Severe Aplastic Anemia into Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell ...Am J Case Rep In Press; DOI: 10.12659/AJCR.943801
14 Mar 2024 : Case report
Potential Indicators of Intestinal Necrosis in Portal Venous Gas: A Case Report of an 82-Year-Old Woman on ...Am J Case Rep In Press; DOI: 10.12659/AJCR.942966
05 Mar 2024 : Case report
Simultaneous Transcatheter Closure of a Ventricular Septal Defect and Pulmonary Valvuloplasty: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942032
06 Mar 2024 : Case report
Successful Healing of Periapical Pathology with Partial Pulpotomy in a Mature Permanent Molar: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942937
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250